AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2015
May 5, 2015
29871_dirs_2015-05-05_41a760e8-7378-47ed-a084-610b3c74df84.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2015-05-05
Reporting Person: Pietrowicz John W. (Sr MD Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-05 | Common Stock Class A | M | 743 | $50.39 | Acquired | 35410 | Direct |
| 2015-05-05 | Common Stock Class A | S | 743 | $90.41 | Disposed | 36153 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-05 | Non-Qualified Stock Option (right to buy) | $50.39 | M | 743 | Acquired | 2015-06-15 | Common Stock Class A (743) | Direct |
Footnotes
F1: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.
F2: As of 6/15/2010, this option vested with respect to 100% of the granted number of shares covered by the option.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Earnings Release
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Remuneration Information
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17